Typicality: | 0.457 |
Saliency: | 0.258 |
since 1984 | 3 | temporal |
mainly | 2 | degree |
in others | 2 | location |
trial → be conducted in → high-income countries | 6 |
trial → be conducted in → developing countries | 5 |
trial → be conducted in → developed countries | 4 |
negative | neutral | positive |
0.133 | 0.705 | 0.162 |
Raw frequency | 15 |
Normalized frequency | 0.258 |
Modifier score | 0.800 |
Perplexity | 33.853 |